Carotid body tumor epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(7 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Carotid body tumor}}
{{Carotid body tumor}}


{{CMG}}; {{AE}} {{Sahar}}
{{CMG}}; {{AE}} {{Sahar}} {{MV}}
==Overview==
==Overview==
 
The [[incidence]] of [[carotid body]] [[tumor]] is less than 3 in 100,000 individuals. It is the most common [[paraganglioma]] of the head and [[neck]] and comprises approximately 65% of [[paragangliomas]]. The [[prevalence]] of head and [[neck]] [[paraganglioma]] is 3% of all [[paraganglioma]]. This [[tumor]] is more commonly observed in the adults and particularly in their fifth decade of life. It affects both gender equally.
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
* The incidence of this tumor is less than 3 in 100,000 individuals.<ref name="WienekeSmith2009">{{cite journal|last1=Wieneke|first1=Jacqueline A.|last2=Smith|first2=Alice|title=Paraganglioma: Carotid Body Tumor|journal=Head and Neck Pathology|volume=3|issue=4|year=2009|pages=303–306|issn=1936-055X|doi=10.1007/s12105-009-0130-5}}</ref>
* The [[incidence]] of this [[tumor]] is less than 3 in 100,000 individuals.<ref name="WienekeSmith2009">{{cite journal|last1=Wieneke|first1=Jacqueline A.|last2=Smith|first2=Alice|title=Paraganglioma: Carotid Body Tumor|journal=Head and Neck Pathology|volume=3|issue=4|year=2009|pages=303–306|issn=1936-055X|doi=10.1007/s12105-009-0130-5}}</ref>
* The incidence of malignant case has been observed to be 10%.<ref name="pmid16520723">{{cite journal |vauthors=Bakoyiannis KC, Georgopoulos SE, Klonaris CN, Tsekouras NS, Felekouras ES, Pikoulis EA, Griniatsos JE, Papalambros EL, Bastounis EA |title=Surgical treatment of carotid body tumors without embolization |journal=Int Angiol |volume=25 |issue=1 |pages=40–5 |date=March 2006 |pmid=16520723 |doi= |url=}}</ref>
* The [[incidence]] of [[malignant]] case has been observed to be 10%.<ref name="pmid16520723">{{cite journal |vauthors=Bakoyiannis KC, Georgopoulos SE, Klonaris CN, Tsekouras NS, Felekouras ES, Pikoulis EA, Griniatsos JE, Papalambros EL, Bastounis EA |title=Surgical treatment of carotid body tumors without embolization |journal=Int Angiol |volume=25 |issue=1 |pages=40–5 |date=March 2006 |pmid=16520723 |doi= |url=}}</ref>
===Prevalence===
===Prevalence===
* The prevalence of carotid body tumor is approximately 65% of head and neck paraganglioma.<ref name="XiaoShe2015">{{cite journal|last1=Xiao|first1=Zebin|last2=She|first2=Dejun|last3=Cao|first3=Dairong|title=Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report|journal=BMC Medical Imaging|volume=15|issue=1|year=2015|issn=1471-2342|doi=10.1186/s12880-015-0082-z}}</ref>
* The [[prevalence]] of [[carotid body]] [[tumor]] is approximately 65% of head and neck [[paraganglioma]].<ref name="XiaoShe2015">{{cite journal|last1=Xiao|first1=Zebin|last2=She|first2=Dejun|last3=Cao|first3=Dairong|title=Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report|journal=BMC Medical Imaging|volume=15|issue=1|year=2015|issn=1471-2342|doi=10.1186/s12880-015-0082-z}}</ref>
* The prevalence of head and neck paraganglioma is 3% of all paraganglioma.
* The [[prevalence]] of head and neck [[paraganglioma]] is 3% of all [[paraganglioma]].
* The estimated prevalence of parasymapathetic paraganglioma is approximately 1-2 cases per 100,000 individuals worldwide.
* The estimated [[prevalence]] of [[parasymapathetic]] [[paraganglioma]] is approximately 1-2 cases per 100,000 individuals worldwide.  
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
===Age===
===Age===
*Carotid body tumor is more commonly observed in the adults and particularly in their fifth decade of life.<ref name="LeeOh2006">{{cite journal|last1=Lee|first1=Ki Yeol|last2=Oh|first2=Yu-Whan|last3=Noh|first3=Hyung Jun|last4=Lee|first4=Yu Jin|last5=Yong|first5=Hwan-Seok|last6=Kang|first6=Eun-Young|last7=Kim|first7=Kyeong Ah|last8=Lee|first8=Nam Joon|title=Extraadrenal Paragangliomas of the Body: Imaging Features|journal=American Journal of Roentgenology|volume=187|issue=2|year=2006|pages=492–504|issn=0361-803X|doi=10.2214/AJR.05.0370}}</ref>
*[[Carotid body]] [[tumor]] is more commonly observed in the adults and particularly in their fifth decade of life.<ref name="LeeOh2006">{{cite journal|last1=Lee|first1=Ki Yeol|last2=Oh|first2=Yu-Whan|last3=Noh|first3=Hyung Jun|last4=Lee|first4=Yu Jin|last5=Yong|first5=Hwan-Seok|last6=Kang|first6=Eun-Young|last7=Kim|first7=Kyeong Ah|last8=Lee|first8=Nam Joon|title=Extraadrenal Paragangliomas of the Body: Imaging Features|journal=American Journal of Roentgenology|volume=187|issue=2|year=2006|pages=492–504|issn=0361-803X|doi=10.2214/AJR.05.0370}}</ref>
*In familial cases, the mean age of onset is younger, being the second or fourth decade of life.<ref name="BurgessCalderon2017">{{cite journal|last1=Burgess|first1=Alfred|last2=Calderon|first2=Moises|last3=Jafif-Cojab|first3=Marcos|last4=Jorge|first4=Diego|last5=Balanza|first5=Ricardo|title=Bilateral carotid body tumor resection in a female patient|journal=International Journal of Surgery Case Reports|volume=41|year=2017|pages=387–391|issn=22102612|doi=10.1016/j.ijscr.2017.11.019}}</ref>
*In [[familial]] cases, the mean age of onset is younger, being the second or fourth decade of life.<ref name="BurgessCalderon2017">{{cite journal|last1=Burgess|first1=Alfred|last2=Calderon|first2=Moises|last3=Jafif-Cojab|first3=Marcos|last4=Jorge|first4=Diego|last5=Balanza|first5=Ricardo|title=Bilateral carotid body tumor resection in a female patient|journal=International Journal of Surgery Case Reports|volume=41|year=2017|pages=387–391|issn=22102612|doi=10.1016/j.ijscr.2017.11.019}}</ref>
===Gender===
===Gender===
*There is no gender preference in the incidence of this tumor according to the recent literature except in the high altitude where the tumor is more prevlent among women.<ref name="BurgessCalderon2017">{{cite journal|last1=Burgess|first1=Alfred|last2=Calderon|first2=Moises|last3=Jafif-Cojab|first3=Marcos|last4=Jorge|first4=Diego|last5=Balanza|first5=Ricardo|title=Bilateral carotid body tumor resection in a female patient|journal=International Journal of Surgery Case Reports|volume=41|year=2017|pages=387–391|issn=22102612|doi=10.1016/j.ijscr.2017.11.019}}</ref><ref name="pmid27316787">{{cite journal |vauthors=Jin ZQ, He W, Wu DF, Lin MY, Jiang HT |title=Color Doppler Ultrasound in Diagnosis and Assessment of Carotid Body Tumors: Comparison with Computed Tomography Angiography |journal=Ultrasound Med Biol |volume=42 |issue=9 |pages=2106–13 |date=September 2016 |pmid=27316787 |doi=10.1016/j.ultrasmedbio.2016.04.007 |url=}}</ref>
*There is no gender preference in the [[incidence]] of this [[tumor]] according to the recent literature except in the high altitude where the [[tumor]] is more prevalent among women.<ref name="BurgessCalderon2017">{{cite journal|last1=Burgess|first1=Alfred|last2=Calderon|first2=Moises|last3=Jafif-Cojab|first3=Marcos|last4=Jorge|first4=Diego|last5=Balanza|first5=Ricardo|title=Bilateral carotid body tumor resection in a female patient|journal=International Journal of Surgery Case Reports|volume=41|year=2017|pages=387–391|issn=22102612|doi=10.1016/j.ijscr.2017.11.019}}</ref><ref name="pmid27316787">{{cite journal |vauthors=Jin ZQ, He W, Wu DF, Lin MY, Jiang HT |title=Color Doppler Ultrasound in Diagnosis and Assessment of Carotid Body Tumors: Comparison with Computed Tomography Angiography |journal=Ultrasound Med Biol |volume=42 |issue=9 |pages=2106–13 |date=September 2016 |pmid=27316787 |doi=10.1016/j.ultrasmedbio.2016.04.007 |url=}}</ref>


===Race===
===Race===
*There is no racial predilection to carotid body tumor.
*There is no racial predilection to [[carotid body]] [[tumor]].


==References==
==References==
Line 30: Line 27:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: Oncology]]
 
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Vascular medicine]]
[[Category:Surgery]]
[[Category:Otolaryngology]]
[[Category:Neurosurgery]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Up-To-Date]]
[[Category:Vascular medicine]]
[[Category:Surgery]]
[[Category:Surgery]]

Latest revision as of 20:49, 29 July 2020

Carotid body tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carotid Body Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carotid body tumor epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carotid body tumor epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carotid body tumor epidemiology and demographics

CDC on Carotid body tumor epidemiology and demographics

Carotid body tumor epidemiology and demographics in the news

Blogs on Carotid body tumor epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Carotid body tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Maria Fernanda Villarreal, M.D. [3]

Overview

The incidence of carotid body tumor is less than 3 in 100,000 individuals. It is the most common paraganglioma of the head and neck and comprises approximately 65% of paragangliomas. The prevalence of head and neck paraganglioma is 3% of all paraganglioma. This tumor is more commonly observed in the adults and particularly in their fifth decade of life. It affects both gender equally.

Epidemiology and Demographics

Incidence

Prevalence

Age

  • Carotid body tumor is more commonly observed in the adults and particularly in their fifth decade of life.[4]
  • In familial cases, the mean age of onset is younger, being the second or fourth decade of life.[5]

Gender

  • There is no gender preference in the incidence of this tumor according to the recent literature except in the high altitude where the tumor is more prevalent among women.[5][6]

Race

References

  1. Wieneke, Jacqueline A.; Smith, Alice (2009). "Paraganglioma: Carotid Body Tumor". Head and Neck Pathology. 3 (4): 303–306. doi:10.1007/s12105-009-0130-5. ISSN 1936-055X.
  2. Bakoyiannis KC, Georgopoulos SE, Klonaris CN, Tsekouras NS, Felekouras ES, Pikoulis EA, Griniatsos JE, Papalambros EL, Bastounis EA (March 2006). "Surgical treatment of carotid body tumors without embolization". Int Angiol. 25 (1): 40–5. PMID 16520723.
  3. Xiao, Zebin; She, Dejun; Cao, Dairong (2015). "Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report". BMC Medical Imaging. 15 (1). doi:10.1186/s12880-015-0082-z. ISSN 1471-2342.
  4. Lee, Ki Yeol; Oh, Yu-Whan; Noh, Hyung Jun; Lee, Yu Jin; Yong, Hwan-Seok; Kang, Eun-Young; Kim, Kyeong Ah; Lee, Nam Joon (2006). "Extraadrenal Paragangliomas of the Body: Imaging Features". American Journal of Roentgenology. 187 (2): 492–504. doi:10.2214/AJR.05.0370. ISSN 0361-803X.
  5. 5.0 5.1 Burgess, Alfred; Calderon, Moises; Jafif-Cojab, Marcos; Jorge, Diego; Balanza, Ricardo (2017). "Bilateral carotid body tumor resection in a female patient". International Journal of Surgery Case Reports. 41: 387–391. doi:10.1016/j.ijscr.2017.11.019. ISSN 2210-2612.
  6. Jin ZQ, He W, Wu DF, Lin MY, Jiang HT (September 2016). "Color Doppler Ultrasound in Diagnosis and Assessment of Carotid Body Tumors: Comparison with Computed Tomography Angiography". Ultrasound Med Biol. 42 (9): 2106–13. doi:10.1016/j.ultrasmedbio.2016.04.007. PMID 27316787.

Template:WH Template:WS